经导管部分脾动脉栓塞术在肝癌TAE中的意义

The Significance of Transcatheter Partial Splenic Arterial Embolization in TAE of Hepatocellular Carcinoma

对18例已行或拟行肝动脉插管栓塞化疗的肝癌病例施行经导管部分脾动脉栓塞术,栓后CT追踪扫描见脾脏均呈进行性缩小,18例患者白细胞、血小板获得满意提高。3例腹水患者栓后3～4周腹水完全吸收;3例术前曾发生食道胃底静脉曲张破裂出血,栓后随访6～12月未见复发。18例患者累积半年、1年生存率分别为100％、55.5％,其中2例生存已超过2年。上述结果表明,经导管部分脾栓塞术对肝癌栓塞化疗后的血象降低或肝癌合并肝硬化所致门脉高压均有较好的治疗作用,因而对提高肝癌TAE后的疗效具有重要意义。

Transcatheter partial splenic arterial embolization had been done in 18 cases of hepatocellular carcinoma prior to or after hepatic arterial chemoembolization. CT follow—up revealed progressive decrease in size of the spleens. The leucocyte and thrombocyte count showed satisfactory improvment. Postoperatively, the ascites, occuerd in 3 cases, completely absorbed within 3-4 weeks and there was no recurrance of hemorrhage due to gastric and esophageal varicosity. The cumulative survival rate of 6 months was 100% and one year 55.5%. The life span of 2 case was over 2 years retrospective. Review of these 18 cases demonstrated that transcatheter partial splenic embolization is an adjutant measure of value in treating thrombocytopenia and leucopenia complicating the patients of hepatocellular carcinoma whom be or have been treated with hepatic arterial chemoembolization.